Status:
COMPLETED
Metformin to Treat Corticosteroids-induced Hyperglycemia
Lead Sponsor:
The Baruch Padeh Medical Center, Poriya
Conditions:
Pregnancy Preterm
Glycemic Control
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
Antenatal corticosteroids, particularly, betamethasone is routinely administered to pregnant women at risk for preterm delivery to improve neonatal outcomes. Although antenatal betamethasone was show...
Eligibility Criteria
Inclusion
- Pregnant women receiving betamethasone from 24 to 36.5 gestational weeks
- Before or within 24 hours following the first dose of betamethasone
- ≥18 years old
Exclusion
- Women with pre-gestational and gestational diabetes mellitus (GDM)
- Known allergic sensitivity to metformin
- Known chronic heart failure
- Known chronic renal failure
- Refuse to participate
- Refuse to perform glucose challenge test/glucose tolerance test later on
Key Trial Info
Start Date :
July 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 5 2025
Estimated Enrollment :
187 Patients enrolled
Trial Details
Trial ID
NCT04332393
Start Date
July 5 2020
End Date
May 5 2025
Last Update
May 9 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Baruch Padeh Medical center, Poriya
Tiberias, North, Israel, 15208
2
Emek medical center
Afula, Israel
3
Galilee medical center
Nahariya, Israel
4
Ziv medical center
Safed, Israel